In a report released today, Linda Bolton Weiser from D.A. Davidson reiterated a Hold rating on Prestige Consumer Healthcare (PBH – Research Report), with a price target of $60.00. The company’s shares closed last Friday at $60.76.
Bolton Weiser covers the Consumer Goods sector, focusing on stocks such as Mattel, Hasbro, and Clarus. According to TipRanks, Bolton Weiser has an average return of 4.2% and a 49.89% success rate on recommended stocks.
Currently, the analyst consensus on Prestige Consumer Healthcare is a Moderate Buy with an average price target of $78.50.
See today’s best-performing stocks on TipRanks >>
PBH market cap is currently $3.02B and has a P/E ratio of -35.93.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare, and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody’s, Beano, Boudreaux’s Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden’s, Monistat, Nix, Pedia-Lax, and Summer’s Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.
Read More on PBH:
